摘要
MicroRNAs(miRNAs)是小的(19–25个核苷酸)转录后基因表达的调控非编码单链RNA。miRNA在脑中大量表达,在神经元分化、突触形成和可塑性的过程中,起着关键的作用。miRNAs参与一些神经系统疾病的病因也正在变得越来越明显。越来越多的证据表明,miRNA调控的信号通路在脑血管疾病如缺血性脑中风,蛛网膜下腔出血,血管性痴呆中有基因信号通路的表达调控能力。例如,miR-21通过动脉粥样硬化涉及缺血性脑中风的病理通路并对其抗凋亡的功能提供了神经保护作用,miR-497诱导了神经元死亡和miR-210在缺氧细胞中的上调。下调表达的miRNAs在应对缺血性中风时,使miRNA的使用可以作为一种有效的非侵入性的生物标志物。Antagomirs往往是有效的抗细胞凋亡因子并且可以诱导神经再生伴随缺血。此外,系统生物学的出现已经引入了新的计算工具来识别miRNA的靶基因之间的联系,并涉及了脑中风的病理及其治疗的转录因子。本文综述了miRNA在神经保护中的作用并且集中于miRNAs作为缺血性中风的核心要素的一个子集。
关键词: 生物标志物;缺血性脑中风;microRNA;神经保护;系统生物学。
图形摘要
Current Drug Targets
Title:ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries
Volume: 17 Issue: 7
Author(s): Sreekala S. Nampoothiri, Hari Vinayak Menon, Debashish Das, Rajanikant Golgodu Krishnamurthy
Affiliation:
关键词: 生物标志物;缺血性脑中风;microRNA;神经保护;系统生物学。
摘要: MicroRNAs (miRNAs) are small (19–25 nucleotides) non-coding single-stranded RNAs that control post-transcriptional gene expression. miRNAs are abundantly expressed in the brain, where they play key roles during neuronal differentiation, synaptogenesis, and plasticity. It is also becoming increasingly evident that miRNAs are involved in the etiology of several neurological disorders. Mounting evidence indicates that miRNAs have the ability to regulate the expression profiles of genes in signaling pathways associated with cerebrovascular diseases such as ischemic stroke, subarachnoid hemorrhage, and vascular dementia. For instance, miR-21 is involved in ischemic stroke pathology through atherosclerosis and provides neuroprotection by its anti-apoptotic features. miR-497 induces neuronal death and miR-210 is upregulated in hypoxic cells. Deregulated expression of miRNAs in response to ischemic stroke has enabled the use of miRNA as an efficient non-invasive biomarker. Antagomirs are often effective against neuronal apoptosis and can induce neuroregeneration following ischemia. Moreover, the advent of systems biology has introduced novel computational tools to identify the link between miRNAs, target genes and transcription factors involved in the stroke pathology and its treatment. This review describes the emerging role of miRNAs in neuroprotection and focuses on a subset of miRNAs that act as central players in ischemic stroke.
Export Options
About this article
Cite this article as:
Sreekala S. Nampoothiri, Hari Vinayak Menon, Debashish Das, Rajanikant Golgodu Krishnamurthy , ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries, Current Drug Targets 2016; 17 (7) . https://dx.doi.org/10.2174/1389450116666150518102404
DOI https://dx.doi.org/10.2174/1389450116666150518102404 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction
Current Pharmaceutical Analysis Editorial [Hot Topic: Analgesic Drug Discovery: Promising Future (Guest Editor: Anindya Bhattacharya)]
Current Pharmaceutical Biotechnology Pharmacological Applications of Antioxidants: Lights and Shadows
Current Drug Targets Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside
Current Vascular Pharmacology Atherogenesis in Renal Patients: A Model of Vascular Disease?
Current Vascular Pharmacology Body Mass Index (BMI) and Cognitive Functions in Later Life
Current Alzheimer Research A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs
Current Drug Targets Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
Current Medicinal Chemistry Why Multiples of 21? Why does Selenoprotein P Contain Multiple Selenocysteine Residues?
Current Nutraceuticals Carbonyl-Scavenging Drugs & Protection Against Carbonyl Stress-Associated Cell Injury
Mini-Reviews in Medicinal Chemistry Olive Oil and Apoptosis of Cancer Cells
Current Nutrition & Food Science Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin
Current Medicinal Chemistry Clinical Management of Arrhythmogenic Right Ventricular Cardiomyopathy: An Update
Current Pharmaceutical Design Role of Sulfur Containing Amino Acids as an Adjuvant Therapy in the Prevention of Diabetes and its Associated Complications
Current Diabetes Reviews The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued)